Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2341 AL 2355

Gastrodin and Gastrodigenin as Potential Neuroprotectors for the Treatment of Neurodegenerative Diseases

Wang J, Chen T, Lin Y, Shen X, Zhou M.

Am J Chin Med. 2026;54(2):529-554. doi: 10.1142/S0192415X26500199. Epub 2026 Feb 21.

Revitalizing mitochondrial quality control: targeting mitochondria-derived vesicles in Parkinson's disease

Mohamed Ameer J, Alexander SM, Navya K, Shenoi RA, Chandra G.

Biochem Pharmacol. 2026 Mar 29;250(Pt 1):117935. doi: 10.1016/j.bcp.2026.117935. Online ahead of print.

Human pluripotent stem cell engineering with CRISPR-Cas9 for Parkinson's disease

Park SB, Kim JS, Ha Y, Kim MS, Kim TW.

Exp Mol Med. 2026 Apr;58(4):993-1009. doi: 10.1038/s12276-026-01679-2. Epub 2026 Apr 10.

FDA-approved drug library screen identifies antidepressants, antimicrobials, anti-COPD, and anti-CVD agents as blockers of NLRP3 inflammasome and sepsis in a sex-dependent manner

Timinski K, Neupane K, Prince A, Bhandari N, Khan MR, Sharma S, Shiravand Y, Traughber CA, Raquepaw Z, Gulshan K.

bioRxiv [Preprint]. 2026 Mar 6:2026.03.05.709979. doi: 10.64898/2026.03.05.709979.

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI

Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee A, Korell M, Meng C, Chen X, Racelo L, Ricci J, Fitzgerald C, Rigby NH, Battles JA, Carley JK, Singh Z, Kruchkow L, McMahon BA, Flagg E, Lemon LP, Talarico JM, Brodkin K, Destro C, Kuhl MM, Fabrizio K, Marek K, Tropea TF; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S80-S87. doi: 10.1002/ana.78245. Epub 2026 May 10.

Multifaceted performances of α-synuclein in health and neurological diseases

Wang M, Xu Y, Wang S, Liang J, Cui X, Zhang C, Yang J, Sun L, Jin M.

Neuroscience. 2026 Apr 16;600:153-162. doi: 10.1016/j.neuroscience.2026.02.031. Epub 2026 Feb 23.

Magnetic Field-Guided Magnetic Nanoparticles as Neurotherapeutics for Neurological Disorders and Glioblastoma

Chiang MC, Yang YP, Nicol CJB.

Life (Basel). 2026 Feb 9;16(2):293. doi: 10.3390/life16020293.

A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease

Ramanan S, Johnson GVW.

J Mol Neurosci. 2026 Apr 2;76(2):57. doi: 10.1007/s12031-026-02514-z.

α-Synuclein Biomarkers for Parkinson's Disease

Lodge A, Agin-Liebes J.

Cold Spring Harb Perspect Med. 2026 Feb 2;16(2):a041944. doi: 10.1101/cshperspect.a041944.

Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice

Cicero CE, Angelini L, Abbadessa G, Bruno M, Fiume G, Nucera B, Ornello R, Arabia G, Giuliano L, Guarnieri B, Lugaresi A, Perani D, Sacco S, Tassorelli C, Nicoletti A, Pellecchia MT; SIN Gender Neurology Study Group and SinDem Sex and gender differences in dementia Study Group.

Neurol Sci. 2026 Jan 6;47(1):108. doi: 10.1007/s10072-025-08623-8.

Micro-nanoplastics and Parkinson's disease: evidence and perspectives

Lin L, Li J, Zhu S, Zhang Z, Li Z, Xu P, Guo W.

NPJ Parkinsons Dis. 2026 Jan 24;12(1):56. doi: 10.1038/s41531-026-01272-4.

Periodic limb movements in Parkinson's disease: a critical review of pathophysiology and a framework for clinical management

Yi S, Liu H, Hu X, Xu J, Zhang S, Zhang H, Wang Z, Han T, Kou L, Xia Y, Wang T, Lin Z, Xiong N.

NPJ Parkinsons Dis. 2026 Apr 15. doi: 10.1038/s41531-026-01356-1. Online ahead of print.

Alpha-synuclein seed amplification assays differentiate synucleinopathies

Dai W, Lin H, Mao H, Kuang Y, Xu P, Li H.

Expert Rev Mol Diagn. 2026 Mar;26(3):223-239. doi: 10.1080/14737159.2026.2663033. Epub 2026 Apr 22.

Dissecting Motor Domain Responses to Vibration Therapy in Parkinson's Disease: A Systematic Review and Meta-Regression Protocol

Park SR, Seo JW, Kim K, Chun JM, Seok JW, Kim JD.

Neurol Ther. 2026 Jun;15(3):951-963. doi: 10.1007/s40120-026-00922-2. Epub 2026 Mar 25.

Association between PTEN-induced kinase 1 (PINK1) rs3738136 polymorphism and Parkinson's disease: A meta-analytic study

Shibi Anilkumar A, Thomas SM, Veerabathiran R.

J Investig Med. 2026 Apr 27:10815589261448841. doi: 10.1177/10815589261448841. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias